Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Nobutoshi Watari is active.

Publication


Featured researches published by Nobutoshi Watari.


Journal of Pharmacokinetics and Biopharmaceutics | 1989

Determination of mean input time, mean residence time, and steady-state volume of distribution with multiple drug inputs

Nobutoshi Watari; Leslie Z. Benet

A general treatment for determination of mean residence time (MRTV)and steady-state volume of distribution (Vss)after multiple drug inputs via any mode of administration is presented. For multiple inputs, either simultaneous or consecutive, the mean input time (MIT)can be readily calculated using the general equations presented here. Sample calculations for (MIT, MRT),and Vssfollowing different combinations of multiple drug inputs are presented. Errors inherent in noncompartmental area determinations are discussed.


Journal of Chromatography B: Biomedical Sciences and Applications | 1988

Simultaneous determination of nitroglycerin and its dinitrate metabolites by capillary gas chromatography with electron-capture detection

Frank W. Lee; Nobutoshi Watari; Jean F. Rigod; Leslie Z. Benet

A sensitive gas chromatographic-electron-capture detection method for the simultaneous determination of the antianginal drug nitroglycerin (GTN) and its dinitrate metabolites (1,2-GDN and 1,3-GDN) was developed. Human plasma samples (1 ml) spiked with 2,6-dinitrotoluene as the internal standard were extracted once with 10 ml of a methylene chloride-pentane mixture (3:7, v/v). Using this solvent system, less contaminants are extracted into the organic phase from plasma, resulting in cleaner chromatograms and prolonged column life. A break point was observed on the standard curves of GTN and GDNs. The two linear regions for the detectable concentrations of GTN are 0.025-0.3 and 0.3-3 ng/ml and for 1,2-GDN and 1,3-GDN they are 0.1-1 and 1-10 ng/ml. The limits of detection by this method for GTN, 1,2-GDN and 1,3-GDN in plasma are 0.025, 0.1 and 0.1 ng/ml, respectively.


Yakugaku Zasshi-journal of The Pharmaceutical Society of Japan | 1987

Dissolution behaviour of carbamazepine polymorphs

Nobuyoshi Kaneniwa; Junichi Ichikawa; Tetsuo Yamaguchi; Kenji Hayashi; Nobutoshi Watari; Masahiro Sumi


Journal of pharmacobio-dynamics | 1986

Study of the absorption site of cimetidine.

Nobuyoshi Kaneniwa; Tomoo Funaki; Shigeru Furuta; Nobutoshi Watari


Journal of pharmacobio-dynamics | 1987

PHARMACOKINETIC STUDY OF CARBAMAZEPINE AND ITS EPOXIDE METABOLITE IN HUMANS

Masahiro Sumi; Nobutoshi Watari; Osamu Umezawa; Nobuyoshi Kaneniwa


Journal of pharmacobio-dynamics | 1989

Comparison of disposition parameters of quinidine and quinine in the rat.

Nobutoshi Watari; Akira Wakamatsu; Nobuyoshi Kaneniwa


Journal of Chromatography B: Biomedical Sciences and Applications | 1986

High-performance liquid chromatographic determination of cimetidine in rat plasma, urine and bile

Nobuyoshi Kaneniwa; Tomoo Funaki; Shigeru Furuta; Nobutoshi Watari


Yakugaku Zasshi-journal of The Pharmaceutical Society of Japan | 1987

Influence of phenobarbital on pharmacokinetics of carbamazepine and its epoxide metabolite in the rabbit

Masahiro Sumi; Nobutoshi Watari; Harutaka Naito; Osamu Umezawa; Nobuyoshi Kaneniwa


Journal of pharmacobio-dynamics | 1989

SPECIES DIFFERENCES IN DISPOSITION OF CARBAMAZEPINE AND ITS EPOXIDE METABOLITE

Masahiro Sumi; Nobutoshi Watari; Nobuyoshi Kaneniwa; Osamu Umezawa


Journal of pharmacobio-dynamics | 1987

A METHOD FOR THE ESTIMATION OF ABSORPTION RATE CONSTANT USING C_ , T_ AND PLASMA LEVEL AFTER T_

Tomoo Funaki; Shigeru Furuta; Nobuyoshi Kaneniwa; Nobutoshi Watari; Mitsuru Hiura

Collaboration


Dive into the Nobutoshi Watari's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge